Key result
WHO/ISH cholesterol charts show excellent agreement with Framingham for 10-year CV risk.
Why the study?
The Framingham Risk Score is widely used for cardiovascular risk estimation, but WHO-ISH risk charts provide region-specific estimates and their comparative performance in primary care in Egypt was unclear.
Do WHO-ISH risk charts agree with the Framingham Risk Score for 10-year cardiovascular risk prediction in adults without established cardiovascular disease?
Cross-Sectional (n=160)
Yes
Do WHO-ISH risk charts agree with the Framingham Risk Score for 10-year cardiovascular risk prediction in adults without established cardiovascular disease?
Effect estimate: weighted κ = 0.86
WHO/ISH cholesterol-based risk charts demonstrate excellent agreement with the Framingham Risk Score for estimating 10-year cardiovascular risk in an Egyptian primary care cohort, whereas non-laboratory charts show only moderate agreement.
Background: Assessment of cardiovascular disease (CVD) risk is essential for prevention and early detection. The Framingham Risk Score (FRS) is one of the most widely used tools for risk estimation. In contrast, the World Health Organization/International Society of Hypertension (WHO-ISH) risk charts were specifically developed to provide region-specific cardiovascular risk estimates. Aim: To compare the risk of 10‑year CVD predictions by the FRS with charts of WHO-ISH risk among adults attending primary care facilities. Methods: A cross-sectional study was conducted between March 2024 and 2025 in randomly selected healthcare facilities in Gharbia, Egypt. A total of 160 adults aged 40 years or older without established cardiovascular disease were included. Participants underwent clinical examination, anthropometric assessment, and laboratory testing. Cardiovascular risk was estimated using both FRS and WHO/ISH charts, and agreement between the methods was assessed using weighted kappa statistics. Results: The participants had a mean age of 54.8 ± 10.2 years; 72.5%. Hypertension (35.6%) and diabetes (22.5%) were the most prevalent comorbidities. FRS classified 32.5% as low risk, while WHO/ISH cholesterol‑based and non‑laboratory charts identified 30.6% and 21.3% as high risk, respectively. Agreement between the different tools was generally strong; excellent agreement was observed between FRS and WHO/ISH cholesterol charts (weighted κ = 0.86), whereas agreement was moderate for both FRS versus non-laboratory charts (κ = 0.66) and between the two WHO/ISH chart versions (κ = 0.68). Conclusion: WHO/ISH charts incorporating cholesterol have strong agreement with the FRS, while the non-laboratory charts show only moderate concordance. These findings indicate agreement between tools rather than predictive accuracy.
No takes yet. Share an insight, caveat, or question.
Elkholy et al. (2026) conducted a cross-sectional in Cardiovascular risk prediction (n=160). WHO/ISH risk charts vs. Framingham Risk Score was evaluated on Agreement between FRS and WHO/ISH charts (weighted κ = 0.86). WHO/ISH cholesterol-based risk charts showed excellent agreement with the Framingham Risk Score for 10-year cardiovascular risk prediction (weighted κ = 0.86).
Synapse has enriched 5 related papers. Consider them for comparative context: